Today we are pleased to welcome Polyphron to the Nolqa portfolio. We invested $670K to support the company as it builds its next stage of growth.
What Polyphron does
Polyphron operates at the intersection of AI and biotechnology, developing technology intended to help address complex biological problems. The company sits within a growing class of businesses using computation to accelerate scientific discovery.
Why we invested
We invested because AI can create leverage well beyond conventional software when it is applied to scientific and biological workflows. Polyphron represents an opportunity to support a technology platform where advances in computation can contribute to new approaches in biotechnology.
What comes next
We will support the team as it develops its technology, validates its scientific applications and builds the foundations for future growth.
We are looking forward to working closely with the team and helping Polyphron build the next chapter of the business.